Literature DB >> 1386516

A molecular model of MHC class-I-restricted antigen processing.

J J Monaco1.   

Abstract

Cells of higher vertebrates have evolved mechanisms that allow a sample of their intracellular contents to be available for surveillance by the immune system. This display of intracellular material is in the form of peptides bound to cell surface major histocompatibility complex (MHC) class I molecules. In this review, John Monaco presents a model of the mechanisms by which this takes place, based on the recent identification of a number of new genes in the MHC.

Mesh：

Substances：

Year:  1992        PMID： 1386516     DOI： 10.1016/0167-5699(92)90122-N

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  101 in total

1.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.

Authors:  J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 2.  The role of adhesion molecules in endothelial cell accessory function.

Authors:  J R Westphal; R M de Waal
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

3.  Frequent segmental sequence exchanges and rapid gene duplication characterize the MHC class I genes in lemurs.

Authors:  Yasuhiro Go; Yoko Satta; Yoshi Kawamoto; Gilbert Rakotoarisoa; Albert Randrianjafy; Naoki Koyama; Hirohisa Hirai
Journal:  Immunogenetics       Date:  2003-10-03       Impact factor: 2.846

4.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

5.  HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

Authors:  Jodie P Goodridge; Ni Lee; Aura Burian; Chul-Woo Pyo; Scott S Tykodi; Edus H Warren; Cassian Yee; Stanley R Riddell; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

Review 6.  Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

Authors:  N P Restifo; Y Kawakami; F Marincola; P Shamamian; A Taggarse; F Esquivel; S A Rosenberg
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-10

7.  Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars.

Authors:  M N Starnbach; M J Bevan; M F Lampe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.

Authors:  M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Bop: a new T-cell-restricted gene located upstream of and opposite to mouse CD8b.

Authors:  I Hwang; P D Gottlieb
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Functional replacement of the hemolysin A transport signal by a different primary sequence.

Authors:  F Zhang; D I Greig; V Ling
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.